bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Oncolytics Biotech Inc. logo

    Oncolytics Biotech Inc.

    ONCY | NASDAQ
    Chart Builder DCF Calculator
    $0.74
    -$0.03 (-3.43%)
    Sep 22, 2026, 11:08 AM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $76.91M
    Enterprise Value
    $73.24M
    Beta
    1.15
    Average Volume
    1.19M
    Shares Outstanding (Diluted)
    119.74M
    Shares Change YoY
    31.58%
    Institutional Ownership
    2.67%
    Exchange
    NASDAQ
    ISIN
    US68237V1035

    Price Performance

    Price Change 1M
    -7.2%
    Price Change 3M
    -18.2%
    Price Change 6M
    -18.9%
    Price Change YTD
    -21.7%
    Price Change 1Y
    -40.8%
    Price Change 3Y
    -64.3%
    Price Change 5Y
    -64.2%
    1M CAGR (ann.)
    -4.5%
    1Y CAGR (ann.)
    -43.6%
    5Y CAGR (ann.)
    -18.3%
    All-Time CAGR
    -15.8%

    Valuation

    PE Ratio
    -3.13
    Forward PE
    N/A
    PEG Ratio
    0.12
    Forward PEG
    0.14
    PS Ratio
    N/A
    Forward PS
    181.70
    PB Ratio
    -12.47
    P/FCF Ratio
    -4.44
    P/Adj. FCF Ratio
    -3.67
    P/OCF Ratio
    -4.43
    EV/Sales
    N/A
    EV/EBIT
    -1.91
    EV/EBITDA
    -1.92
    EV/FCF
    -3.06
    Earnings Yield
    -31.4%
    FCF Yield
    -22.1%
    Adj. FCF Yield
    -26.8%

    Financial Health

    Net Cash
    C$4.12M
    Total Debt
    C$448K
    Cash & Short-Term Investments
    C$4.12M
    Total Assets
    C$7.67M
    Current Ratio
    1.35
    Quick Ratio
    1.35
    Debt / Equity Ratio
    -0.07
    Debt / EBITDA
    -0.01
    Debt / FCF
    -0.02
    OCF / Debt
    -53.39
    Interest Coverage
    0.00
    Altman Z-Score
    -94.63
    Piotroski F-Score
    1

    Margins & Profitability

    Gross Profit Margin
    0.0%
    Operating Profit Margin
    0.0%
    EBITDA Margin
    0.0%
    Net Profit Margin
    0.0%
    FCF Margin
    N/A
    Adj. FCF Margin
    N/A
    SBC / Revenue
    0.0%
    SBC Impact (per share)
    -21.0%

    Returns

    Return on Assets
    -498.1%
    Return on Equity
    1020.2%
    Return on Invested Capital
    -1480.5%
    Return on Capital Employed
    -1564.0%
    Return on Tangible Assets
    -498.1%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    N/A
    Revenue CAGR 5Y
    N/A
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    6.1%
    EPS CAGR 5Y
    10.0%
    EPS CAGR 10Y
    17.0%
    FCF CAGR 3Y
    5.9%
    FCF CAGR 5Y
    3.2%
    FCF CAGR 10Y
    -5.7%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    1
    EPS Growth Next 3Y
    7.8%
    Revenue Growth Next 3Y
    N/A
    Earnings Date
    Nov 10, 2026
    EPS Estimate (next Q)
    -$0.05
    EPS Growth Est (next Q)
    -30.0%
    Revenue Est (next Q)
    N/A
    Revenue Growth Est (next Q)
    N/A

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $5
    Price Target Upside
    549.4%

    Cash Flow

    Operating Cash Flow
    C$-23.92M
    Free Cash Flow
    C$-23.92M
    Adj. Free Cash Flow
    C$-28.94M
    FCF Per Share
    -$0.24
    OCF Per Share
    -$0.24
    OCF/S Ratio
    0.0%

    Income Statement

    Revenue
    C$0
    Gross Profit
    C$0
    Operating Income
    C$-38.26M
    EBITDA
    C$-38.17M
    Net Income
    C$-38.21M
    EPS (Diluted)
    -$0.34
    Revenue / Employee
    N/A
    Profit / Employee
    $-1.32M
    Employees
    29

    © 2026 bestshares.com. All rights reserved.